Coverage map

Learn about your coverage options

#AccessForAll is our advocacy initiative to ensure equitable and universal access to diabetes devices for all Canadians, regardless of age. We aim to support the T1D community to increase both public and private coverage for advanced glucose monitors (Flash CGM and Continuous Glucose Monitors) and insulin pumps. We believe in patient choice and the importance of reducing out of pocket costs for these life changing and life saving devices.

Choose a province below to see coverage of diabetes tech and types of insulin in your province.

QC Qc BC C.-B. AB Alb. SK Sask. MB Man. ON Ont. NU Nt NT T.N.-O. YT Yn NL T.-N.-L. PEI Î.-P.-É. NB N.-B. NS N.-É.

Available Devices in Alberta

In response to the public, the government will no longer be making changes to the Insulin Pump Therapy Program. The program will continue as it was designed, and the government commits to add access to the next generation of insulin pumps starting as soon as possible this year.

  • Coverage for insulin pumps is provided through Alberta’s Insulin Pump Therapy Program and patients must:
    • be a resident of Alberta who is eligible for coverage under the Alberta Health Care Insurance Plan.
    • be diagnosed with Type 1 diabetes or Type 3c diabetes and be under the care of a physician or nurse practitioner for the condition.
    • meet and continue to meet the clinical criteria as set out in the Insulin Pump Therapy Program – Clinical Criteria.
    • complete a pre-insulin pump information session.
    • complete an insulin pump therapy (IPT) education plan.
    • attend at least one assessment at a Clinic
    • complete a Patient Responsibility Form.
    • have a completed an Eligibility Notification Form.
    • have been sent a Confirmation Letter.
    • participate in required reviews and ongoing clinical monitoring by the Clinic Team.
    • have not been sent a Letter of Clinical Ineligibility.
    • have not been sent a Discontinuation Letter.
  • Additional Information: https://www.albertahealthservices.ca/services/page8548.aspx
Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid Acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Short-Acting regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Insulin Lispro/lispro protamine
suspension (Humalog Mix25)
Humalog Mix50

Available Devices in British Columbia

Insulin pump coverage in British Columbia is available to people who:

  • Are covered under Fair PharmaCare, Plan C (Income Assistance), Plan F (At Home Program), or Plan W (First Nations Health Benefits), and
  • Have type 1 diabetes or another form of diabetes requiring insulin, and
  • Have confirmation from their endocrinologist or diabetes specialist that they meet the medical criteria, and
  • Have Special Authority approval for coverage

For more information, please visit: https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/what-we-cover/diabetes-supplies/insulin-pumps-insulin-pump-supplies

PharmaCare provides coverage of a continuous glucose monitor (CGM) and a flash glucose monitor (FGM) through Special Authority. Initial coverage is for 1 year. After the first year, your prescriber can request a Special Authority renewal for 5 years.

You are eligible for coverage if:

  • You are covered under one (or more) of these plans:
  • Fair PharmaCare
  • Plan C (Income Assistance)
  • Plan F (At Home Program)
  • Plan W (First Nations Health Benefits)
  • Blood glucose testing with a CGM/FGM has been deemed medically necessary for you
  • You agree to comprehensive and age-appropriate diabetes education by an interdisciplinary diabetes healthcare team and commit to regular follow-up

If you are already using a CGM/FGM and would like to be covered by PharmaCare, your prescriber will still need to apply for Special Authority. You must meet the eligibility criteria. You do not need a certificate of training from a diabetes education centre to qualify for this coverage.

CGMs, FGMs and blood glucose test strips

If using a CGM/FGM, you may occasionally need blood glucose test strips (for example, if your monitor displays an error code or if your symptoms don’t match your readings). CGM and FGM users are covered for 200 blood glucose test strips per year.

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid Acting Aspart (NovoRapid) *
Glulisine (Apidra) *
Lispro (Humalog) *
Short-Acting regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Biphasic Insulin Aspart (NovoMix 30) *
Insulin Lispro/lispro protamine suspension (Humalog Mix25) *
Humalog Mix50 *

 

* BC Pharmacare provides partial reimbursement for rapid-acting insulins and patients must pay the difference

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Short-acting Pork regular insulin (Hypurin Regular)
Long-acting basal analogues Detemir (Levemir)
Pork isophane insulin (Hypurin NPH)

Note: Exceptional coverage may occur for people whose endocrinologist/ diabetes physician determines these two systems are unsuitable for them.

Available Devices in Manitoba

The Manitoba Adult Insulin Pump Coverage Program provides coverage for eligible Manitobans 18 years of age and older with type 1 diabetes who need this device. For more information, please visit: https://www.gov.mb.ca/health/mhsip/healthcoverage.html#ancillary-ten.

Manitobans under the age of 18 can access insulin pumps through the Manitoba Pediatric Insulin Pump Program. For more information, please visit: https://residents.gov.mb.ca/forms.html?d=details&pub_id=1475&filter_dept=11

Anyone with type 1 or type 2 diabetes requiring the use of insulin and who meets the eligibility criteria available here is eligible for an advanced glucose monitor through the Pharmacare Program.

For more information, please visit: https://sharedhealthmb.ca/files/agm-expansion-patient-faqs.pdf

Anyone with type 1 or type 2 diabetes requiring the use of insulin and who meets the eligibility criteria available here is eligible for an advanced glucose monitor through the Pharmacare Program. For more information, please visit: https://sharedhealthmb.ca/files/agm-expansion-patient-faqs.pdf

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Lispro (biosimilar) (Admelog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)
Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Insulin Lispro/lispro protamine suspension (Humalog Mix25)

Available Devices in New Brunswick

The New Brunswick Insulin Pump Program supports New Brunswickers of all ages living with type 1 diabetes who are medically eligible for insulin pump therapy.
For more information, please visit: https://www2.gnb.ca/content/gnb/en/departments/health/patientinformation/PrimaryHealthCare/A-Comprehensive-Diabetes-Strategy-for-New-Brunswickers/TheNewBrunswickInsulinPumpProgram-IPP.html

No Coverage

Financial support for CGM is available for medically eligible New Brunswickers living with type 1 diabetes. For more information, please visit: https://www2.gnb.ca/content/gnb/en/departments/health/patientinformation/PrimaryHealthCare/A-Comprehensive-Diabetes-Strategy-for-New-Brunswickers/TheNewBrunswickInsulinPumpProgram-IPP.html

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (biosimilar) (Admelog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)

 

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Lispro (Humalog)
Long-acting basal analogues Detemir (Levemir)

Available Devices in Newfoundland and Labrador

  • Insulin Pumps are covered in Newfoundland and Labrador under the province’s Insulin Pump Program. Individuals must:
    • have been diagnosed with type 1 Diabetes Mellitus (T1DM);
    • be a resident of Newfoundland and Labrador;
    • have a valid medical care plan (MCP) card;
    • meet medical eligibility criteria; and
    • if 18 years of age or older, meet the requirements for financial assistance through an income testing criteria.
  • Additional Information: https://www.easternhealth.ca/find-health-care/nlipp/

No coverage

Anyone living with T1D in Newfoundland and Labrador who meets the medical and income-testing criteria will be eligible for full or partial coverage of continuous glucose monitors. For more information, please see the government’s announcement here: https://www.gov.nl.ca/releases/2025/health/0522n01/

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)

 

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Lispro (Humalog)
Long-acting basal analogues Detemir (Levemir)

Available Devices in Nova Scotia

Nova Scotia’s Insulin Pump Program is open to all ages and provides coverage for insulin pump and supplies subject to eligibility. Please visit here for more information: https://www.novascotia.ca/apply-funding-insulin-pump-and-supplies-insulin-pump-program

Nova Scotia’s Sensor-based Glucose Monitoring Program is available for Nova Scotians who are 2 or older and helps pay for approved sensor-based glucose monitoring systems that are listed in the Nova Scotia Formulary.

Please visit here for more information: https://www.novascotia.ca/register-sensor-based-glucose-monitoring-program

Nova Scotia’s Sensor-based Glucose Monitoring Program is available for Nova Scotians who are 2 or older and helps pay for approved sensor-based glucose monitoring systems that are listed in the Nova Scotia Formulary. Please visit here for more information: https://www.novascotia.ca/register-sensor-based-glucose-monitoring-program

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)

 

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Lispro (Humalog) *
Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)

 

* NS: Humalog – full benefit for children under 18

Available Devices in Northwest Territories

All ages are covered, as well as 100% of the pump supplies.

The Freestyle Libre and Freestyle Libre 2 are covered under NT Pharmacare for:

  • Children 19 years of age and younger on intensive insulin therapy (administration of short-acting insulin three or more times per day).
  • Clients with type 1 diabetes, as verified by short-acting insulin claims history.

The Dexcom G6 and Dexcom G7 are covered under NT Pharmacare for:

  • Children 19 years of age and younger on intensive insulin therapy (administration of short-acting insulin three or more times per day).
  • Clients with type 1 diabetes, as verified by short-acting insulin claims history.
Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)
Glargine U300 (Toujeo)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Insulin Lispro/lispro protamine suspension (Humalog Mix25)
Humalog Mix50

 

Available Devices in Nunuvut

All ages are covered, as well as 100% of the pump supplies.

No coverage

No coverage

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)
Glargine U300 (Toujeo)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Insulin Lispro/lispro protamine suspension (Humalog Mix25)
Humalog Mix50

 

Available Devices in Ontario

Coverage for Flash GM is provided in Ontario under the Ontario Drug Benefit program for those living with T1D who meet specific medical eligibility criteria.

For more information, please visit: https://www.ontario.ca/page/get-coverage-prescription-drugs#diabetes

 

Coverage for CGM is provided in Ontario under the Assistive Devices Program for those living with T1D who meet specific medical eligibility criteria.

For more information, please visit: https://www.ontario.ca/page/get-support-for-diabetes-equipment-and-supplies

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Glulisine (Apidra)
Lispro (Humalog)
Lispro (biosimilar) (Admelog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)
Glargine U300 (Toujeo)
Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Biphasic Insulin Aspart (NovoMix 30)
Insuin Lispro/lispro protamine suspension (Humalog Mix25)

 

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)

Available Devices in Prince Edward Island

Funding assistance for glucose sensor systems are accepted through the P.E.I. Glucose Sensor Program, giving Islanders access to these devices at reduced costs through local pharmacies.

Eligibility criteria:

  • a permanent resident as defined by the Drug Cost Assistance Act
  • a valid PEI Health Card
  • Filed your most recent income tax return
  • Are diagnosed by a medical practitioner or nurse practitioner as having diabetes and
  • Are reliant on an insulin pump or multiple daily injections of insulin (i.e. 3 or more) to manage your diabetes and
  • Have a signed Special Authorization form from your medical practitioner, nurse practitioner or certified diabetes educator.

Funding assistance for glucose sensor systems are accepted through the P.E.I. Glucose Sensor Program, giving Islanders access to these devices at reduced costs through local pharmacies.

Eligibility criteria:

  • a permanent resident as defined by the Drug Cost Assistance Act
  • a valid PEI Health Card
  • Filed your most recent income tax return
  • Are diagnosed by a medical practitioner or nurse practitioner as having diabetes and
  • Are reliant on an insulin pump or multiple daily injections of insulin (i.e. 3 or more) to manage your diabetes and
  • Have a signed Special Authorization form from your medical practitioner, nurse practitioner or certified diabetes educator.
Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Insulin Lispro/lispro protamine suspension (Humalog Mix25)

 

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)
Glargine U300 (Toujeo)

Available Devices in Quebec

Insulin pumps are covered in Quebec by RAMQ under the Insulin Pump Access Program. People under 18 years of age must meet a set of clinical criteria to qualify for the program. Eligibility for the program must be re-evaluated annually. Persons admitted to the program may continue to participate in it after age 18 if they still meet the clinical eligibility criteria.

For more information, please visit: https://www.quebec.ca/en/health/health-issues/a-z/diabetes/insulin-pump-access-program

Funding assistance for glucose sensor systems are accepted through the P.E.I. Glucose Sensor Program, giving Islanders access to these devices at reduced costs through local pharmacies.

Eligibility criteria:

  • are a PEI resident as defined by the Drug Cost Assistance Act,
  • have a valid PEI Health Card,
  • filed your most recent income tax return for the most recent year, and rely on an insulin pump or three or more daily injections of insulin to manage your diabetes

Funding assistance for glucose sensor systems are accepted through the P.E.I. Glucose Sensor Program, giving Islanders access to these devices at reduced costs through local pharmacies.

Eligibility criteria:

  • are a PEI resident as defined by the Drug Cost Assistance Act,
  • have a valid PEI Health Card,
  • filed your most recent income tax return for the most recent year, and rely on an insulin pump or three or more daily injections of insulin to manage your diabetes
Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Lispro (biosimilar) (Admelog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine U300 (Toujeo)
Degludec (Tresiba)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Humalog Mix50

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Long-acting basal analogues Glargine (biosimilar) (Basaglar)
Pre-mixed insulins Biphasic Insulin Aspart (NovoMix 30)
Insuin Lispro/lispro protamine suspension (Humalog Mix25)

Available Devices in Saskatchewan

Saskatchewan Insulin Pump Program eligibility is based on an assessment through a Saskatchewan Health Authority diabetes education program process, which includes meeting the medical criteria detailed in the Insulin Pump Program policy.

For adults with type 1 diabetes:

  • An application must be submitted on behalf of a client by an SHA diabetes education program or an authorized diabetes specialist physician.

For children (under the age of 18) with type 1 diabetes:

  • A Pediatric Insulin Pump Program application must be submitted on behalf of the client by an SHA pediatric diabetes education program or an authorized pediatric diabetes specialist physician.
  • The screening and insulin pump assessment process includes attendance at a Pediatric Diabetes Pump Information Session or completion of the Is Pump Therapy for Me? online modules and quiz.

For more information, please visit: https://www.saskatchewan.ca/residents/health/accessing-health-care-services/insulin-pump-program

Saskatchewan provides full coverage for continuous and flash glucose monitors (advanced glucose monitors) to seniors aged 65 and older, young adults aged 18 to 25, and children up to age 18. For more information, please visit: https://formulary.drugplan.ehealthsask.ca/Bulletins/Bulletin-0252-Mar-2025.pdf

Saskatchewan provides full coverage for continuous and flash glucose monitors (advanced glucose monitors) to seniors aged 65 and older, young adults aged 18 to 25, and children up to age 18. For more information, please visit: https://formulary.drugplan.ehealthsask.ca/Bulletins/Bulletin-0252-Mar-2025.pdf

Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Glulisine (Apidra)
Lispro (Humalog)
Short-Acting Lispro (biosimilar) (Admelog)
Regular (Humulin-R, Novolin ge Toronto)
Pork regular insulin (Hypurin Regular)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Detemir (Levemir)
Glargine (Lantus)
Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pork isophane insulin (Hypurin NPH)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)

Available Devices in Yukon

All ages are covered, as well as 100% of the pump supplies.

  • Flash GMs are covered for all ages and physicians will apply for coverage on behalf of their patients
  • If adults prefer to use a continuous glucose monitor, they can apply their flash glucose monitor coverage to the cost of a continuous glucose monitor.
  • To be eligible for the benefit, Yukoners with type 1 diabetes who meet the benefit criteria must register with the Chronic Disease and Disability Benefit program at 867-667-5092. People aged 65 or older can contact the Pharmacare program at 867-667-5403.
  • CGMs are covered for all ages and physicians will apply for coverage on behalf of their patients
  • If adults prefer to use a flash glucose monitor, they can apply their continuous glucose monitor coverage to the cost of a flash glucose monitor.
  • To be eligible for the benefit, Yukoners with type 1 diabetes who meet the benefit criteria must register with the Chronic Disease and Disability Benefit program at 867-667-5092. People aged 65 or older can contact the Pharmacare program at 867-667-5403.
Listed

Can be prescribed by any doctor. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Aspart (NovoRapid)
Glulisine (Apidra)
Lispro (Humalog)
Short-Acting Regular (Humulin-R, Novolin ge Toronto)
Pork regular insulin (Hypurin Regular)
Basal Insulins Intermediate acting – regular NPH (Humulin-N, Novolin GE NPH)
Long-acting basal analogues Glargine (biosimilar) (Basaglar)
Degludec (Tresiba)
Pork isophane insulin (Hypurin NPH)
Pre-Mixed Insulin Premixed Regular-NPH (Humulin 30/70, Novolin 30/70-40/60-50/50)
Biphasic Insulin Aspart (NovoMix 30)
Insulin Lispro/lispro protamine suspension (Humalog Mix25)
Humalog Mix50

 

 

Restricted

Only available to those who meet eligibility criteria and receive prior approval from the drug benefit plan. Cost will be fully or partially covered according to the terms of the public drug plan.

Rapid-acting Lispro (Humalog)
Long-acting basal analogues Detemir (Levemir)

No details are available for this province or territory

Private coverage

If your employer/insurer doesn’t cover diabetes devices, we’ve produced a toolkit with lots of helpful advice to support your advocacy for expanded coverage.

Visit this resource for more information.

Donate | Donnez